TREACE MEDICAL CONCEPTS INC Share Price Today: Live Updates & Key Insights

TREACE MEDICAL CONCEPTS INC share price today is $1.34, up -2.88%. The stock opened at $1.37 against the previous close of $1.39, with an intraday high of $1.4 and low of $1.3401.

TREACE MEDICAL CONCEPTS INC Share Price Chart

TREACE MEDICAL CONCEPTS INC

us-stock
To Invest in {{usstockname}}
us-stock

TREACE MEDICAL CONCEPTS INC Share Price Performance

$1.34 -0.0288(-2.88%) TMCI at 13 Mar 2026 03:32 PM Medical Devices
Lowest Today 1.3401
Highest Today 1.4
Today’s Open 1.37
Prev. Close 1.39
52 Week High 8.87
52 Week Low 1.31
Day’s Range: Low 1.3401 High 1.4
52-Week Range: Low 1.31 High 8.87
1 day return -
1 Week return -6.25
1 month return -27.41
3 month return -51.17
6 month return -81.31
1 year return -83.09
3 year return -94.11
5 year return -94.82
10 year return -

TREACE MEDICAL CONCEPTS INC Institutional Holdings

Armistice Capital, LLC 9.85

BlackRock Inc 5.70

JPMorgan Chase & Co 5.00

Gagnon Securities LLC 4.82

Vanguard Group Inc 3.52

Millennium Management LLC 2.65

Gagnon Advisors, LLC 2.38

Atlantic Trust Group, LLC 2.29

Arnhold & S. Bleichroeder Advisers, LLC 2.27

First Eagle Small Cap Opportunity I 2.05

First Eagle US Small Cap Strategy 1.98

iShares Russell 2000 ETF 1.81

Geode Capital Management, LLC 1.77

William Blair Investment Management, LLC 1.77

State Street Corp 1.54

Vanguard Total Stock Mkt Idx Inv 1.48

Deutsche Bank AG 1.44

Morgan Stanley - Brokerage Accounts 1.18

CenterBook Partners LP 1.04

D. E. Shaw & Co LP 0.98

Vanguard Institutional Extnd Mkt Idx Tr 0.79

Fidelity Small Cap Index 0.72

Northern Trust Corp 0.67

iShares Russell 2000 Growth ETF 0.62

Charles Schwab Investment Management Inc 0.55

GSA Capital Partners LLP 0.54

State St Russell Sm/Mid Cp® Indx SL Cl I 0.47

Acuitas Investments, LLC 0.47

Acuitas US Microcap Strategy 0.47

Schwab US Small-Cap ETF™ 0.36

Vanguard Russell 2000 ETF 0.35

State St Russell Sm Cap® Indx SL Cl I 0.26

Fidelity Extended Market Index 0.24

Vanguard Health Care ETF 0.24

Blackrock Extended Mkt Fund CF 0.20

Schwab Small Cap Index 0.19

First Eagle US Small Cap Opp I-UC 0.17

Extended Equity Market Fund K 0.17

NT R2000 Index Fund - NL 0.17

Xtrackers MSCI World Swap ETF 1C 0.16

TREACE MEDICAL CONCEPTS INC Market Status

Strong Buy: 2

Buy: 0

Hold: 5

Sell: 0

Strong Sell: 0

TREACE MEDICAL CONCEPTS INC Fundamentals

Market Cap 89.78 M

PB Ratio 1.028

PE Ratio 0.0

Enterprise Value 113.28 M

Total Assets 190.58 M

Volume 493136

TREACE MEDICAL CONCEPTS INC Company Financials

Annual Revenue FY23:174675000 174.7M, FY22:141838000 141.8M, FY21:94419000 94.4M, FY20:57365000 57.4M, FY19:39416000 39.4M

Annual Profit FY23:139951000 140.0M, FY22:114315000 114.3M, FY21:76593000 76.6M, FY20:44895000 44.9M, FY19:31785000 31.8M

Annual Net worth FY23:-47658000 -47.7M, FY22:-47298000 -47.3M, FY21:-24612000 -24.6M, FY20:-6445000 -6.4M, FY19:-5106000 -5.1M

Quarterly Revenue Q3/2025:50214000 50.2M, Q2/2025:47387000 47.4M, Q1/2025:52570000 52.6M, Q3/2024:45086000 45.1M, Q2/2024:44455000 44.5M

Quarterly Profit Q3/2025:39706000 39.7M, Q2/2025:37752000 37.8M, Q1/2025:41893000 41.9M, Q3/2024:36132000 36.1M, Q2/2024:35674000 35.7M

Quarterly Net worth Q3/2025:-16288000 -16.3M, Q2/2025:-17398000 -17.4M, Q1/2025:-15922000 -15.9M, Q3/2024:-15360000 -15.4M, Q2/2024:-21206000 -21.2M

About TREACE MEDICAL CONCEPTS INC & investment objective

Company Information Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Organisation Medical Devices

Employees 450

Industry Medical Devices

CEO Mr. John T. Treace

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right